Ben Lamm’s $30M AI Venture Surfaces from Stealth

SEC Filings Reveal Astromech 

Ben Lamm has been busy. While the Colossal Biosciences co-founder has been publicly working on bringing back woolly mammoths, he's also been quietly building something else entirely: a $30 million artificial intelligence company called Astromech. 

SEC filings have pulled back the curtain on Ben Lamm's latest venture, revealing that he and Harvard genetics researcher George Church have successfully raised substantial funding for their AI startup. The catch? Almost nobody knew it existed until now. 

Operating in Stealth 

In an era where every startup announcement comes with flashy press releases and demo videos, Ben Lamm has taken a completely different approach with Astromech. The company operates in strict stealth mode, incorporated in Delaware with virtually no public presence beyond the mandatory SEC documentation. 

What's particularly intriguing is that Ben Lamm is pulling double duty, continuing his work at Colossal Biosciences while simultaneously building Astromech with George Church. This isn't a typical entrepreneur pivot – it's a strategic expansion that suggests Ben Lamm sees massive potential in AI applications for biotechnology. 

The $30M Question: What Is Astromech Actually Building? 

Here's where things get interesting. Ben Lamm and Church have managed to secure serious funding without revealing their hand about what Astromech actually does. The stealth approach leaves observers connecting dots between their backgrounds in de-extinction technology and genetic restoration at Colossal Biosciences. 

George Church brings heavyweight scientific credentials in genetics and synthetic biology, while Ben Lamm contributes proven experience scaling biotechnology operations. Together, they've attracted $30 million in investment for an AI venture that remains deliberately mysterious. 

Why Investors Are Paying Attention 

That Astromech could attract $30 million without going public with its product underscores the credibility of its founders. Lamm’s track record with Colossal—pursuing bold projects once considered science fiction—has already shown his ability to execute at the edge of possibility. 

Now, Astromech’s stealth posture seems less about secrecy and more about control: advancing the technology before the noise, speculation, and competition set in. 

What Comes Next 

The reveal of Astromech doesn’t end its mystery—it heightens it. For now, details remain scarce, but one thing is clear: Ben Lamm and George Church are positioning themselves at the frontier of AI in biotechnology. With $30 million in backing and a stealth runway, Astromech is a company worth watching closely.